The authors identified an inverse relationship between SMAD3 upregulation in AD pericytes and vascular endothelial growth factor downregulation in AD astrocytes in Ab42-treated zebrafish lines, which was further supported by pharmacological analyses. Here, SMAD3 is linked to Alzheimer disease.